Abstracts Present your research or case study on General Menopause Hormones and Hormone Action Cardiovascular System Musculoskeletal Health to the opening of abstract submissions The Abstract submission will be opened soon See the rules TOPICS GUIDELINES CALENDAR PRESENTATION Topics for abstracts General menopause Epidemiology, basic science and clinical researchDiagnosis of menopauseSymptoms of menopause including vasomotor symptomsBiochemical prediction of age at menopauseHormone and non-hormonal therapyPremature ovarian insufficiencyThe menopause after cancerMenopause and COVID-19Menopause in the work place Vulvovaginal atrophy/genitourinary syndrome of menopauseVulvovaginal atrophy/genitourinary syndrome of menopauseTreatment options (including vaginal estrogens and laser)DermatogynecologyMicrobiota and urogenital healthLower urinary tract symptoms including incontinence ad recurrent UTIsPelvic organ prolapse Hormones and hormone actionHormones and hormone receptor signaling mechanismsBiological actions of sex steroidsSelective hormone receptor modulatorsNovel treatments and regimens Hormones and metabolism ObesityMetabolic syndromeInsulin resistance, diabetes and dyslipidemiaOther topics related to hormones and the metabolism Sexual function Epidemiology, basic science and clinical researchTreatment options – psychological and medical approaches Menopause and cardiovascular system Epidemiology, basic science and clinical researchHormones and coronary heart diseaseHormones and thrombosisHormones and cerebrovascular disease Menopause and the brain Neurosteroids and actionsCognitive functionSleep and sleep disordersAlzheimer’s disease and other neurodegenerative disorders Mood and mental disorders Epidemiology, basic science and clinical researchHormonal and non-hormonal treatment of mood disorders (including perimenopausal and premenstrual depression)Schizophrenia and other mental disorders Musculoskeletal health Prevalence, epidemiology and consequences of fragility fractureBone loss and osteoporosisSarcopeniaPharmacological and non-pharmacological fracture prevention Breast health Breast and breast cancer biology Breast cancer epidemiology Hormone therapy and breast cancer Imaging in breast cancer (screening and diagnostic) Breast cancer prevention (life style/pharmacotherapy) Tolerance and aromatase inhibitor-related side effects Adjuvant bisphosphonates Gynecology Abnormal uterine bleeding Management of fibroids – medical and surgical Endometriosis (in perimenopause and consequences of surgery) PCOS – implications for menopause Endometrial hyperplasia and cancer Vulval and vaginal conditions Diagnostic gynecology Other oncology Hormones and non-gynecological cancer Screening, diagnosis and treatment of women Treatment consequences in relation to the menopause Novel non hormonal treatment regimens Women at high genetic risk of female cancers e.g. BRCA, Lynch syndrome Other health issues Autoimmune disorders Neurological conditions Sensory functions ABSTRACT GUIDELINES Before you submit Registration for the Congress is not required to submit an abstract. Each person is allowed to submit a maximum of two abstracts on the congress’ topics as presenting author: one oral presentation and one poster or, alternatively, two posters. There is no limit to the number of abstracts submitted as co-author. It’s allowed to submit abstracts already presented in other conferences or Scientific Journals Presenting authors of accepted abstracts are entitled to register at the special fee communicated along with the acceptance email. Prepare your paper Abstracts should be structured into the following sections if applicable: Context – Objective – Methods – Patient(s) – Intervention(s) – Main Outcome Measure(s) – Result(s) – Conclusions. The abstract cannot be longer than 2500 characters including spaces, and must be plain text. It is not possible to include tables and images, but you may insert data in the text of the abstract. Submission Abstracts can only be submitted using the on-line form. Abstracts submitted via email are automatically discarded. Submit you abstract following the online submission process and upload your file in the appropriate field. Once accepted, abstract cannot be modified in any of its parts (authors, content and title) Abstracts received after the deadline will not be accepted. Acceptance Presenting authors of accepted abstracts will be notified within 15 March 2024 whether their abstract is accepted. The correctness of the authors’ personal details is entirely up to the responsibility of the author who has submitted the abstract. The submitting author will be also responsible for all the communication (please make sure that a valid email is submitted). The abstract submission indicates acknowledgement and consent for publication in the official program as well as in GREM Journal CALENDAr OF DEADLINES October 19 2023 Opening of the Abstract Submission June 24 2024 DEADLINE FOR ORAL PRESENTATIONS The Scientific Committee will consider the abstracts not accepted as Oral Presentations for possible inclusion in the Poster Session. August 20 2024 DEADLINE FOR POSTERS From August 8 to 27 2024 Acceptance The submitted abstracts will be under a blind-review process. After that, all the abstract submitters will be communicated whether their abstract is accepted. The acceptance letters will be sent between 8 and 27 August. September 10 2024 REGISTRATION Speakers whose abstracts have been accepted must complete their congress registration before September 10 2024 . The Abstract submission will be opened soon The accepted abstracts will be divided into Oral Presentations and Poster Session. Rules for presentation will be available after the acceptance in the account page. The Oral Presentation SessionsThe Oral Presentation Sessions will be held at the Congress Venue and each presentation will be made available for the virtual congress. The Poster Sessionwill be organized at the Congress Venue. All the authors will be requested to bring their printed poster at the congress venue and to upload a PDF to be made available for the virtual congress.